Aims: Many studies have been demonstrating the role of mitochondrial function in acetaminophen (APAP) hepatotoxicity. Since APAP is commonly consumed with caffeine, this work evaluated the effects of the combination of APAP and caffeine on hepatic mitochondrial bioenergetic function in mice. Main methods: Mice were treated with caffeine (20 mg/kg, intraperitoneal (i.p.)) or its vehicle and, after 30 minutes, APAP (250 mg/kg, i.p.) or its vehicle. Four hours later, livers were removed, and the parameters associated with mitochondrial function and oxidative stress were evaluated. Hepatic cellular oxygen consumption was evaluated by high-resolution respirometry (HRR). Key findings: APAP treatment decreased cellular oxygen consumption and mitochondrial complex activities in the livers of mice. Additionally, treatment with APAP increased swelling of isolated mitochondria from mice livers. On the other hand, caffeine administered with APAP was able to improve hepatic mitochondrial bioenergetic function. Treatment with APAP increased lipid peroxidation and reactive oxygen species (ROS) production and decreased glutathione levels in the livers of mice. Caffeine administered with APAP was able to prevent lipid peroxidation and the ROS production in mice livers, which may be associated with the improvement of mitochondrial function caused by caffeine treatment. Significance: We suggest that the antioxidant effects of caffeine and/or its interactions with mitochondrial bioenergetics may be involved in its beneficial effects against APAP hepatotoxicity.
Introduction
Acetaminophen (paracetamol, N-acetyl-p-aminophenol, APAP) is a classical non-steroidal anti-inflammatory drug (NSAID) that is widely consumed as an analgesic and antipyretic medication. However, APAP overdose may cause hepatic injury, leading to acute liver failure (ALF) [1] . Liver damage caused by high doses of APAP is associated with Nacetyl-p-benzoquinone imine (NAPQI) formation, a reactive metabolite that is formed by the cytochrome P-450 (CYP450) enzyme family [2] .
One important mechanism involved in APAP overdose is the disruption of hepatic mitochondrial metabolism [3, 4] . Mitochondria are the main target of NAPQI [5] which causes functional alterations in calcium metabolism, complexes I and II inhibition and decreased adenosine triphosphate (ATP) levels. The oxidative phosphorylation process results in an increase of ions and metabolic intermediates in mitochondria, causing mitochondrial swelling [6] . These events impair mitochondrial function and ultimately lead to cell death [1] . In this way, the mitochondrial permeability transition is one of the mechanisms involved in APAP-induced impairment of hepatic mitochondria [4] .
Conversely, endogenous antioxidants, such as glutathione, and exogenous antioxidant compounds can protect mitochondria against cellular oxidative damage such as APAP-induced stress [7] . In this regard, caffeine, a methylxanthine alkaloid compound present in beverages (coffee, tea, energy drinks), food (chocolate, desserts) and medicines, has long been considered as an antioxidant molecule. Accumulating evidence has suggested a potential antioxidant role for caffeine [8] [9] [10] . Chemical studies have proposed the reactive oxygen production (ROS) scavenging properties of caffeine, particularly of the hydroxyl radical (OH%) [11] [12] [13] [14] . However, the effects of caffeine on mitochondrial bioenergetics have been poorly investigated until now.
Caffeine is also frequently used as an analgesic drug adjuvant in several over-the-counter medications [15, 16] . Drugs such as aspirin, diclofenac and APAP are largely combined with caffeine [17] and readily available in drugstores for relief of pathological (or pathologyrelated) symptoms such as dysregulated body temperature [18] .
Studies on the analgesic effects of drugs used for pain relief, such as APAP, have shown that the combination of APAP with caffeine reduces the drug dosage necessary to produce the same analgesic effect when compared to APAP alone [16, 17, 19] . However, there is a lack of studies that investigate effects on mitochondrial liver function in drugs that combine caffeine with analgesics such as APAP. Usually, studies on caffeine and APAP association focus on the analgesic effects [17, 20, 21] . In addition, the role of APAP in poisoning mitochondrial metabolism is already known, but the effect of caffeine and APAP association on mitochondria remains unclear [1, 22] . Therefore, the aim of the present study is to investigate the effect of APAP and caffeine association on hepatic mitochondrial bioenergetics in mice.
Materials and methods

Animals
Forty male adult swiss albino mice (2 months old, 30-40 g) from our own breeding colony were divided into groups of four or five animals for the biochemical assays. The animals were kept in a separate animal room, with light/dark cycles of 12 h each, at a temperature of 22 ± 2°C, with free access to food and water. This study was approved by the Ethical and Animal Welfare Committee of the Federal University of Santa Maria, Brazil, under the process number 3208150915/2015.
Experimental protocol
The animals were randomly divided into four groups, with three or four animals per group, depending on the analysis: (1) control saline, (2) caffeine, (3) APAP and (4) caffeine plus APAP. The doses of caffeine (20 mg/kg) and APAP (250 mg/kg) used in these procedures were described previously [23, 24] and were administered by intraperitoneal injection (i.p.). The APAP dose of 250 mg/kg was chosen because this dose produces mild hepatotoxicity, based on serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and moderate mitochondrial damage is preferable to distinguish the caffeine effect from that of APAP alone to evaluate the effect of the APAP and caffeine combination on mitochondrial bioenergetics. To study the effects of APAP and caffeine association on mitochondrial bioenergetics, the i.p. route of administration was chosen, since both compounds, caffeine and APAP, would not suffer any alteration during its passage through the gastrointestinal tract. The animals were fasted for 16 h [25] before starting the experimental protocol. Fig. 1 portrays the experimental protocol used in this study. The animals were pre-treated with caffeine or saline 30 min before APAP administration. Four hours after APAP administration, animals were sacrificed, and the livers were immediately removed for biochemical analyses according to previous studies [26, 27] .
Mitochondria isolation from the livers of mice
Mouse liver mitochondria were isolated at 4°C by differential centrifugation [28] . After removal, livers were immersed and homogenized proportionally 1/10 (weight/volume) in ice-cold isolation buffer I containing 320 mM sucrose, 1 mM ethylene glycol-bis (2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 1 mM ethylenediaminetetraacetic acid (EDTA) and 10 mM Trizma-base, pH 7.4. The resulting suspension was centrifuged for 10 min at 2500 × g in a Hitachi CR 21E centrifuge. The supernatant was centrifuged at 10,000 × g for 10 min. The pellet was re-suspended in 200 μL of isolation buffer I with bovine serum albumin (BSA) containing 320 mM sucrose, 1 mM EDTA, 1 mM EGTA, 0.1% fatty acid free BSA and 10 mM Trizma-base, pH 7.4. The resulting supernatant was decanted, and the final pellet was gently washed and re-suspended in isolation buffer II containing 250 mM sucrose and 10 mM Trizma base, pH 7.4. The pellet was washed three times with isolation buffer II, and finally, the pellet was re-suspended, also in isolation buffer II consisting of intact mitochondria. Isolated mitochondria were used in the mitochondrial swelling assay and mitochondrial reduced glutathione (GSH) content assay.
ROS production assay
ROS generation was determined spectrofluorimetrically in liver homogenate using 2′7′dichlorodihydrofluorescein diacetate (H 2 DCF-DA) (1 mM). The oxidation of H 2 DCF to 2′7′dichlorofluorescein (DCF) is used as an index of the peroxide production by cellular components [29] . Briefly, liver homogenate was added to the standard medium, and the fluorescence was determined at 488 nm for excitation and 525 nm for emission, with slit widths of 3 nm.
Measurement of thiobarbituric acid reactive substances (TBARS)
Lipid peroxidation (LPO) was determined by measuring thiobarbituric acid reactive substances (TBARS) [30] . An aliquot (200 μL) of liver homogenate was mixed with 500 μL thiobarbituric acid (0.6%), 200 μL sodium dodecyl sulfate (SDS) 8.1%, and 500 μL acetic acid (pH 3.4) and incubated at 90°C for 1 h. TBARS levels were measured at 532 nm using a standard curve of malondialdehyde (MDA), and the results were reported as nmol MDA/mg protein.
High-resolution respirometry (HRR) assay
For the respirometry determination, mice livers were weighed and homogenized in 2 mL of cold buffer containing 5 mM Tris-HCl, 250 mM sucrose and 2 mM EGTA (pH = 7.4) and transferred into the Oxygraph2k (O2k, OROBOROS INSTRUMENTS, Innsbruck) 2-mL chambers. Oxygen polarography was performed at 37°C, and the oxygen flux was recorded in real time using DatLab software. In the present protocol, the liver homogenate (0.1 mg/mL) was added to the chamber containing the mitochondrial respiration medium (MIR05) (0.5 mM EGTA, 3 mM MgCl 2 , 60 mM lactobionic acid, 20 mM taurine, 10 mM KH 2 PO 4 , 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 110 mM sucrose, 0.1 mg/mL fatty acid free BSA). After signal stabilization, the experimental protocol of high-resolution respirometry was performed by sequential addition of 10 mM glutamate, 2 mM malate, 2.5 mM adenosine diphosphate (ADP), 10 mM succinate, 0.5 μM rotenone and 2.5 μM antimycin A [31] [32] [33] . We used tissue homogenates for the analysis of mitochondrial respiration instead of isolated mitochondria because the mitochondrial isolation process can remove > 60% of the mitochondrial population compared to tissue homogenate, impair the mitochondria structure and functionality, and disrupt the mitochondrial network [34] .
Mitochondrial swelling assay
Measurements of mitochondrial swelling were performed using an RF-5301 Shimadzu spectrofluorometer at 600 nm with 1.5-nm slits for excitation and emission. Mitochondria (0.1 mg protein) were incubated in buffer II containing 250 mM sucrose and 10 mM Trizma base at pH 7.4 [35] . This mitochondrial swelling assay requires the use of isolated mitochondria in order to obtain more reliable results [36] .
Fluorimetric assay of mitochondrial reduced glutathione (GSH)
GSH levels were determined in isolated mitochondria by fluorescence detection using a previously described method [37] . Isolated liver mitochondria (0.5 mg protein) re-suspended in 1.5 mL phosphate-EDTA buffer and 500 μL H 3 PO 4 (4.5%) were rapidly centrifuged at 100,000 ×g (Hitachi, TL-100 ultracentrifuge) for 30 min. For GSH determination, 100 μL of supernatant was added to 1.8 mL phosphate buffer and 100 μL O-Phthalaldehyde (OPT). After mixing and incubating at room temperature for 15 min, the solution was transferred to a quartz cuvette, and the fluorescence was measured at 420 nm and 350 nm of emission and excitation wavelengths, respectively. GSH levels were determined from comparisons with a linear GSH standard curve.
In vitro total antioxidant capacity assay
The total antioxidant potential of caffeine and its metabolites, theophylline and theobromine, were evaluated by the phosphomolybdenum method [38] . Caffeine, theophylline, theobromine and 3,5-Di-tert-4-butylhydroxytoluene (BHT), (used as positive control) were tested at concentrations of 0.1, 1, 10, 100 and 1000 μM. The vials were capped and incubated at 95°C for 90 min. After cooling the mixture to room temperature, the absorbance was measured at 695 nm using a Spectra Max Plate Reader® M2 (Molecular Devices), Sunnyvale, California, USA.
Protein determination
Protein was determined by Bradford's test [39] using serum albumin as a standard.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6, with one-way analysis of variance (ANOVA), followed by Newman-Keul's test for post hoc comparison. Data are expressed as the means ± Standard Error of Mean (S.E.M.), p values < 0.05 were considered significant.
Results
Caffeine improves hepatic mitochondrial bioenergetics in livers of APAP-treated mice
The effect of caffeine, APAP and the combination of both on hepatic mitochondrial bioenergetics was investigated by HRR. Coupled respiration was measured using different mitochondrial respiratory chain substrates and saturated concentrations of ADP (Fig. 3) , enabling oxidative phosphorylation (OXPHOS). LEAK state was assessed in the absence of ADP, causing OXPHOS inactivation. This protocol probed mitochondrial bioenergetics functionality by evaluating the oxygen consumption by different mitochondrial complex substrates in the coupled respiratory chain and the oxidative phosphorylation process [40] .
Our protocol to measure respiration consisted of titration with different substrates and inhibitors that allowed specific responses by the coupled mitochondrial respiratory chain. In Fig. 3 , the effect of caffeine and/or APAP treatments was not significant in the LEAK state, which measures the mitochondrial function in the absence of ADP and, consequently, without OXPHOS.
The respiratory control ratio (RCR) values (Table 1) compare the mitochondrial function in the presence of different substrates and saturated ADP concentrations (OXPHOS) (Fig. 3 ) with the mitochondria state in which there is no oxidative phosphorylation (LEAK) (OXPHOS/ LEAK) (Fig. 3) . Treatment with APAP and caffeine alone did not significantly alter RCR values compared with the control group. However, treatment with caffeine plus APAP caused a significant increase in RCR values when compared to the control and APAP groups in CI & CII respiration. Since the RCR is indicative of mitochondrial functionality, the increase in RCR values in the caffeine alone and caffeine plus APAP groups is associated with an increase in hepatic mitochondrial respiration.
Caffeine decreased mitochondrial swelling in the liver of APAP-treated mice
Hepatic mitochondrial swelling (Fig. 4) was not altered by treatment with caffeine alone when compared to the control group. However, the APAP group presented a marked increase in mitochondrial swelling when compared to the control group. In the livers of mice treated with caffeine plus APAP, mitochondrial swelling levels were undistinguishable from values of the control group. 
Caffeine decreased oxidative stress markers in livers of APAP-treated mice
Treatment with caffeine alone did not alter TBARS levels (Fig. 5A ) in liver tissue. On the other hand, treatment with APAP caused a significant increase in hepatic TBARS levels compared to the control group. In the livers of mice treated with caffeine plus APAP, TBARS levels were similar to those of the control group.
ROS production (DCFH oxidation, Fig. 5B ) in the livers of mice treated with caffeine did not differ from the control group. Treatment with APAP significantly increased the DCFH oxidation in mice livers, and treatment with caffeine plus APAP did not present differences in DCFH oxidation compared to the control group. Fig. 6 shows the GSH content in isolated mitochondria from the livers of mice treated with caffeine and/or APAP. The group treated with caffeine did not present differences in mitochondrial GSH content when compared to the control group. However, the APAP alone and caffeine plus APAP groups presented significant decreases in Fig. 2 . Representative figure of the real-time, high-resolution respirometry experiments for each treatment group. Basal respirometry (BASAL), indicates the state without oxidative phosphorylation. LEAK is the state with addition of glutamate and malate (GM). Oxidative phosphorylation (OXPHOS) starts by addition of ADP, the increase in respiration observed is related to complex I (CI) activity, then it was added succinate and, the increase in oxygen consumption observed is related to complex I and II (CI & CII) activities. Rotenone (ROT), a complex I inhibitor, was added to observe the respiration activity only by complex II (CII). Lastly, it was added antimycin A (AmA), an inhibitor of cytochrome c reductase, to obtain the residual oxygen consumption (ROX). 
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mitochondrial GSH levels when compared to the control group.
Caffeine and its metabolites presented in vitro antioxidant activity
The scavenger ability of caffeine, theobromine and theophylline was evaluated in comparison with a known scavenger of reactive species using the total antioxidant activity assay [38] . The results (Table 2) demonstrate that caffeine and its metabolites, theobromine and theophylline, presented antioxidant activity when compared to a positive control. The results suggest that both caffeine and its metabolites present scavenger activity on concentrations above 1 μM, with similar results for the concentrations of 1 to 1000 μM.
Discussion
The present study investigated the effect of caffeine and APAP association on hepatic mitochondrial bioenergetic functionality. Mitochondrial dysfunction is an extensively studied mechanism in APAP-induced hepatotoxicity [41] . The effects of APAP overdose include inhibition of mitochondrial complexes, especially complex I and II, a decrease of ATP levels, and mitochondrial swelling [1] . Other studies demonstrate the role of NAPQI, which binds with cellular structures, on APAP toxicity, since it can form mitochondrial adducts and cause mitochondrial dysfunction [42] .
The APAP dose (250 mg/kg) used in the present study was not capable of causing evident hepatotoxicity, which was confirmed by the serum levels of ALT and AST (data not shown). However, this dose clearly influenced mitochondrial function, interfering with the respiratory chain complexes, respiratory control ratio and cellular oxidative stress markers. Therefore, this dose was useful for assessing the influence of caffeine and APAP association on mitochondrial bioenergetic parameters.
Our analysis of the interdependent pathways of mitochondrial complexes was performed based on OXPHOS (Fig. 3) . Our results concur with previous studies that demonstrate the inhibitory effect of APAP on mitochondrial complex I and complex II from rat hepatocytes [3] . It is interesting to note that caffeine induces a compensatory response mediated by mitochondrial complex II, increasing mitochondrial respiration to the same levels of the control group. Therefore, the decrease of complex I by APAP was counterbalanced by a significant increase in respiration related to complex II that maintained the phosphorylation at the same levels of the control group. The same effect was also observed in relation to complex III. RCR results (Table 1) emphasize the modulatory effect of caffeine to improve hepatic mitochondrial function [32, 43, 44] , as demonstrated by an increase in oxygen consumption by the livers of mice treated with caffeine alone and caffeine plus APAP.
In general, this result indicates an improvement in the hepatic mitochondrial respiratory function by caffeine, preventing the mitochondrial oxidative phosphorylation inhibition by APAP. To the best of our knowledge, this is the first time that the effect of caffeine in combination with APAP on hepatic mitochondrial respiration has been investigated. Caffeine health benefits have been attributed to its antioxidant and ergogenic properties [8] [9] [10] , although there are few studies relating caffeine and mitochondrial bioenergetics [45, 46] .
Considering the common association of caffeine with other drugs [17] , it is relevant to investigate the effects of this combination on 
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Life Sciences 193 (2018) [234] [235] [236] [237] [238] [239] [240] [241] mitochondrial [45] parameters. Caffeine is a known antagonist of purinergic receptors [47, 48] , which justifies the use of caffeine as a support analgesic. On the other hand, caffeine also seems to interfere with mitochondrial metabolism [45] . Other studies demonstrate that caffeine can improve mitochondrial function [46] by increasing metabolic capacity and mitochondrial biogenesis [44] . Caffeine's effects on mitochondrial bioenergetics could occur through antagonism of specific purinergic receptors, such as P2Y [49] , which are found on the mitochondrial membrane and are involved with mitochondrial calcium uptake. The antagonism of P2Y receptors decreases mitochondrial calcium uptake, leading to metabolic effects [50] . Calcium uptake regulates the stimulation of respiratory chain enzymes, the increase in ATP production and the opening of permeability transition pores, increasing mitochondrial swelling and leading to apoptosis [51] . According to our results, caffeine demonstrates a protective effect on APAP-induced mitochondrial swelling, suggesting a possible antagonistic effect of caffeine on the P2Y pathway, resulting in decreased calcium uptake, closed transition pores and stimulation of the respiratory chain, as observed by HRR evaluation. In addition, mitochondrial swelling may be related to the oxidative stress induced by APAP. The overproduction of ROS impairs mitochondrial respiration, resulting in mitochondrial permeability transition and increased calcium uptake by mitochondria [1] . In this way, caffeine's protective effect on APAP-induced oxidative stress and mitochondrial damage could also be associated with its antioxidant effects.
The increase of ROS production leads to cellular oxidative stress and is known [52] to interfere in mitochondrial function, decrease ATP generation and in extreme cases lead to cell death [53] . To observe if the protective effects of caffeine could be associated with its antioxidant properties, we decided to evaluate oxidative stress markers in the livers of mice treated with caffeine and/or APAP. Indeed, APAP treatment enhanced ROS production (DCFH oxidation, Fig. 5B ) and increased TBARS production (Fig. 5A ) in the livers of mice. Association with caffeine protected from APAP-induced reactive species and TBARS production in mice livers. This result corroborates the antioxidant effect of caffeine and its metabolites [12, 13] , which was previously demonstrated by other studies, and has been attributed to the scavenger ability of these molecules. The scavenger ability of caffeine and its metabolites was confirmed by the in vitro total antioxidant activity assay (Table 2) , which demonstrated that both caffeine and its metabolites present antioxidant activity compared to a positive control.
Mitochondrial antioxidant defenses are also very important to the mitigation of oxidative damage. In this way, GSH is an important cellular antioxidant defense that can preserve mitochondrial functionality in APAP-induced hepatotoxicity by reducing the toxic metabolite NAPQI [54] . We analyzed the effect of caffeine and APAP association on mitochondrial GSH levels (Fig. 6) . GSH depletion is a classic consequence of APAP hepatotoxicity, since GSH is responsible for the neutralization of NAPQI [42] . Our results demonstrate that APAP treatment decreased hepatic mitochondrial GSH levels, and the association of caffeine with APAP did not prevent mitochondrial GSH depletion, indicating that caffeine did not interfere in APAP metabolism and NAPQI levels. These data support the conclusion that the action of caffeine to reduce APAP-induced oxidative stress in the liver is not linked with a decrease of NAPQI metabolite levels or an increase of endogenous antioxidant mitochondrial defenses, such as GSH. Instead, we suggest that the antioxidant effect of caffeine observed here is probably related to the cellular scavenge of reactive species [12] .
Overall, the results presented here demonstrate that APAP treatment interferes in hepatic mitochondrial functionality by decreasing mitochondrial respiration and impairing the activity of mitochondrial complexes, mainly complex I. These events can provoke an additional increase of ROS production in the liver. Caffeine prevented the hepatic oxygen consumption decrease induced by APAP treatment by improving mitochondrial respiration in complex II and maintaining complex III activity. Interestingly, caffeine also prevented the mitochondrial swelling caused by APAP in the livers of mice. Caffeine promoted the decrease of hepatic ROS production and lipid peroxidation induced by APAP, which may explain its well-known antioxidant properties. Furthermore, caffeine treatment increased the RCR ratio of mitochondria from the livers of mice, indicating an improvement in mitochondrial respiration. This effect of caffeine needs to be investigated in detail in further studies.
Conclusions
In conclusion, the results presented here suggest that the association of caffeine with APAP does not increase the hepatoxicity induced by APAP but rather presents a beneficial effect on mitochondrial bioenergetics, thus improving hepatic mitochondrial respiration, possibly through caffeine's antioxidant properties and/or via its interactions with mitochondrial purinergic receptors.
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